Exaggerated Mitophagy: a Weapon of Striatal Destruction in the Brain?

Overview

Journal Biochem Soc Trans

Specialty Biochemistry

Date 2020 Mar 5

PMID 32129826

Citations 7

Authors

Srinivasa Subramaniam

Affiliations

Soon will be listed here.

Abstract

Mechanisms responsible for neuronal vulnerability in the brain remain unclear. Striatal neurons are preferentially damaged by 3-nitropropionic acid (3-NP), a mitochondrial complex-II inhibitor, causing striatal damage reminiscent of Huntington's disease (HD), but the mechanisms of the selectivity are not as well understood. We have discovered that Rhes, a protein enriched in the striatum, removes mitochondria via the mitophagy process. The process becomes intensified in the presence of 3-NP, thereby eliminating most of the mitochondria from the striatum. We put forward the hypothesis that Rhes acts as a 'mitophagy ligand' in the brain and promotes mitophagy via NIX, a mitophagy receptor. Since Rhes interacts and promotes toxicity in association with mutant huntingtin (mHTT), the genetic cause of HD, it is tempting to speculate on whether the exaggerated mitophagy may be a contributing factor to the striatal lesion found in HD. Thus, Rhes-mediated exaggerated mitophagy may act as a weapon of striatal destruction in the brain.

Citing Articles

PolyQ-Expansion Causes Mitochondria Fragmentation Independent of Huntingtin and Is Distinct from Traumatic Brain Injury (TBI)/Mechanical Stress-Mediated Fragmentation Which Results from Cell Death.

Swinter K, Salah D, Rathnayake R, Gunawardena S Cells. 2023; 12(19).

PMID: 37830620 PMC: 10572422. DOI: 10.3390/cells12192406.

Mitophagy-promoting agents and their ability to promote healthy-aging.

Srivastava V, Gross E Biochem Soc Trans. 2023; 51(5):1811-1846.

PMID: 37650304 PMC: 10657188. DOI: 10.1042/BST20221363.

Mitophagy regulation in aging and neurodegenerative disease.

Banarase T, Sammeta S, Wankhede N, Mangrulkar S, Rahangdale S, Aglawe M Biophys Rev. 2023; 15(2):239-255.

PMID: 37124925 PMC: 10133433. DOI: 10.1007/s12551-023-01057-6.

The role of autophagy in death of cardiomyocytes.

Ikeda S, Zablocki D, Sadoshima J J Mol Cell Cardiol. 2021; 165:1-8.

PMID: 34919896 PMC: 8940676. DOI: 10.1016/j.yjmcc.2021.12.006.

Mitochondrial Dysfunction and Mitophagy in Fuchs Endothelial Corneal Dystrophy.

Kumar V, Jurkunas U Cells. 2021; 10(8).

PMID: 34440658 PMC: 8392447. DOI: 10.3390/cells10081888.

References

Sbodio J, Paul B, Machamer C, Snyder S . Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease. Cell Rep. 2013; 4(5):890-7. PMC: 3801179. DOI: 10.1016/j.celrep.2013.08.001. View

Damiano M, Diguet E, Malgorn C, DAurelio M, Galvan L, Petit F . A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet. 2013; 22(19):3869-82. PMC: 3766181. DOI: 10.1093/hmg/ddt242. View

Mealer R, Subramaniam S, Snyder S . Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease. J Neurosci. 2013; 33(9):4206-10. PMC: 3667505. DOI: 10.1523/JNEUROSCI.3730-12.2013. View

Yablonska S, Ganesan V, Ferrando L, Kim J, Pyzel A, Baranova O . Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23. Proc Natl Acad Sci U S A. 2019; 116(33):16593-16602. PMC: 6697818. DOI: 10.1073/pnas.1904101116. View

Sandhir R, Sood A, Mehrotra A, Kamboj S . N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease. Neurodegener Dis. 2012; 9(3):145-57. DOI: 10.1159/000334273. View

Li M, Yang X, Wang S . PTEN enhances nasal epithelial cell resistance to TNFα‑induced inflammatory injury by limiting mitophagy via repression of the TLR4‑JNK‑Bnip3 pathway. Mol Med Rep. 2018; 18(3):2973-2986. DOI: 10.3892/mmr.2018.9264. View

Young-Collier K, McArdle M, Bennett J . The dying of the light: mitochondrial failure in Alzheimer's disease. J Alzheimers Dis. 2011; 28(4):771-81. DOI: 10.3233/JAD-2011-111487. View

Pleasure I, Black M, Keen J . Valosin-containing protein, VCP, is a ubiquitous clathrin-binding protein. Nature. 1993; 365(6445):459-62. DOI: 10.1038/365459a0. View

Dany M, Gencer S, Nganga R, Thomas R, Oleinik N, Baron K . Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML. Blood. 2016; 128(15):1944-1958. PMC: 5064718. DOI: 10.1182/blood-2016-04-708750. View

10.

Subramaniam S, Napolitano F, Mealer R, Kim S, Errico F, Barrow R . Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. Nat Neurosci. 2011; 15(2):191-3. PMC: 3267880. DOI: 10.1038/nn.2994. View

11.

Schulz J, Henshaw D, MacGarvey U, Beal M . Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem Int. 1996; 29(2):167-71. DOI: 10.1016/0197-0186(95)00122-0. View

12.

Coles C, Edmondson D, SINGER T . Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem. 1979; 254(12):5161-7. View

13.

Akkaya B, Roesler A, Miozzo P, Theall B, Al Souz J, Smelkinson M . Increased Mitochondrial Biogenesis and Reactive Oxygen Species Production Accompany Prolonged CD4 T Cell Activation. J Immunol. 2018; 201(11):3294-3306. PMC: 6246812. DOI: 10.4049/jimmunol.1800753. View

14.

Harrison L . Rhes: a GTP-binding protein integral to striatal physiology and pathology. Cell Mol Neurobiol. 2012; 32(6):907-18. PMC: 3396771. DOI: 10.1007/s10571-012-9830-6. View

15.

Shi R, Zhu S, Li V, Gibson S, Xu X, Kong J . BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neurosci Ther. 2014; 20(12):1045-55. PMC: 6492992. DOI: 10.1111/cns.12325. View

16.

Baiamonte B, Lee F, Brewer S, Spano D, Lahoste G . Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease. PLoS One. 2013; 8(1):e53606. PMC: 3549908. DOI: 10.1371/journal.pone.0053606. View

17.

Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V . The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Mol Cell Neurosci. 2007; 37(2):335-45. DOI: 10.1016/j.mcn.2007.10.007. View

18.

Shahani N, Swarnkar S, Giovinazzo V, Morgenweck J, Bohn L, Scharager-Tapia C . RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum. Sci Signal. 2016; 9(454):ra111. PMC: 5142824. DOI: 10.1126/scisignal.aaf6670. View

19.

Singh S, Jamwal S, Kumar P . Piperine Enhances the Protective Effect of Curcumin Against 3-NP Induced Neurotoxicity: Possible Neurotransmitters Modulation Mechanism. Neurochem Res. 2015; 40(8):1758-66. DOI: 10.1007/s11064-015-1658-2. View

20.

Patergnani S, Pinton P . Mitophagy and mitochondrial balance. Methods Mol Biol. 2014; 1241:181-94. DOI: 10.1007/978-1-4939-1875-1_15. View